NHGRI logo

Division of Genome Sciences

The Division of Genome Sciences supports and accelerates foundational resources, technology development, experimental approaches, in basic genomics and functional genomics research.  The Division also oversees a number of transformational initiatives and programs in genomic sciences.

Overview

The division supports and accelerates foundational resources, technology development, experimental approaches, data science and analytical tools that transform genome science to facilitate research on the function of the genome in human health and disease. In conducting it's mission, the division also:

  • Assesses the need for research and research training in genome sciences and related areas.
  • Determines program priorities in genome sciences and related areas and recommends funding levels.
  • Prepares reports and analyses to assist institute staff and advisory groups in carrying out their responsibilities.
  • Collaborates with the other NHGRI extramural research divisions to establish a balance of resources, personnel, and research and training budgets to achieve NHGRI goals.
  • Provides expert advice to the director of NHGRI on various aspects of genome sciences.
  • Collaborates with the other NHGRI divisions, other National Institutes of Health Institutes and Centers, and other agencies and entities, nationally and internationally.
  • Maintains an awareness of research efforts in relevant program areas.
  • Overview

    The division supports and accelerates foundational resources, technology development, experimental approaches, data science and analytical tools that transform genome science to facilitate research on the function of the genome in human health and disease. In conducting it's mission, the division also:

    • Assesses the need for research and research training in genome sciences and related areas.
    • Determines program priorities in genome sciences and related areas and recommends funding levels.
    • Prepares reports and analyses to assist institute staff and advisory groups in carrying out their responsibilities.
    • Collaborates with the other NHGRI extramural research divisions to establish a balance of resources, personnel, and research and training budgets to achieve NHGRI goals.
    • Provides expert advice to the director of NHGRI on various aspects of genome sciences.
    • Collaborates with the other NHGRI divisions, other National Institutes of Health Institutes and Centers, and other agencies and entities, nationally and internationally.
    • Maintains an awareness of research efforts in relevant program areas.

Research Programs

Unsolicited, Investigator-Initiated Research

NHGRI strongly supports unsolicited, investigator-initiated research, which are funded under NIH-wide “parent” Program Announcements (PAs), as well as PAs or PARs targeting specific scientific topics. Investigator-initiated means you create an application in any area of science NIH supports. 

 

To learn more about the research areas we support and the appropriate contacts, please visit the Content Map for Contacts by Research Area or the Contacts by Research Area: Search.

 

For more information, please visit NHGRI's Research Funding.

Funding Opportunities

  • Centers of Excellence in Genomic Science (RM1 Clinical Trial Optional)
    PAR-22-107
    Application Receipt Date(s): June 21, 2024
    Expiration Date: June 22, 2024
  • Molecular Phenotypes of Null Alleles in Cells (MorPhiC) Phase I: Data Analysis and Validation Centers (U01 Clinical trials not allowed)
    RFA-HG-22-019
    Application Due Dates: November 1, 2022
    Expiration Date: November 2, 2022
  • Molecular Phenotypes of Null Alleles in Cells (MorPhiC) Phase I: Data Analysis and Validation Centers (U01 Clinical trials not allowed)
    RFA-HG-22-019
    Application Due Dates: November 1, 2022
    Expiration Date: November 2, 2022
  • Technology Development for Single-Molecule Protein Sequencing (R43/R44 Clinical Trial not allowed)
    PAR-21-247
    Application Due Dates: October 1, 2021; June 15, 2022; June 15, 2023
    Expiration Date: June 16, 2023
  • Technology Development for Single-Molecule Protein Sequencing (R01 Clinical Trial not allowed)
    RFA-HG-21-001
    Application Receipt Date(s): October 1, 2021; June 15, 2022; June 15, 2023 |
    Expiration Date: June 16, 2023
  • Technology Development for Single-Molecule Protein Sequencing (R21 Clinical Trial not allowed)
    RFA-HG-21-002
    Application Receipt Date(s): October 1, 2021; June 15, 2022; June 15, 2023
    Expiration Date: June 16, 2023
  • Notice of Special Interest (NOSI): Advancing Genomic Technology Development for Research and Clinical Application
    NOT-HG-21-018
  • Transformative Nucleic Acid Sequencing Technology Innovation and Early Development (R01 Clinical Trial not Allowed)
    RFA-HG-21-006
    Application Receipt Dates: June 25, 2021; March 1, 2022; February 1, 2023
    Expiration Date: February 2, 2023
  • Transformative Nucleic Acid Sequencing Technology Innovation and Early Development (R21 Clinical Trial not Allowed)
    RFA-HG-21-007
    Application Receipt Dates: June 25, 2021; March 1, 2022; February 1, 2023
    Expiration Date: February 2, 2023
  • Transformative Nucleic Acid Sequencing Technology Innovation and Early Development (R43/R44)
    RFA-HG-21-008
    Application Receipt Dates: June 25, 2021; March 1, 2022; February 1, 2023
    Expiration Date: February 2, 2023
  • Notice of Special Interest (NOSI): High-throughput Molecular and Cellular Phenotyping
    NOT-HG-21-004
  • Funding Opportunities
    • Centers of Excellence in Genomic Science (RM1 Clinical Trial Optional)
      PAR-22-107
      Application Receipt Date(s): June 21, 2024
      Expiration Date: June 22, 2024
    • Molecular Phenotypes of Null Alleles in Cells (MorPhiC) Phase I: Data Analysis and Validation Centers (U01 Clinical trials not allowed)
      RFA-HG-22-019
      Application Due Dates: November 1, 2022
      Expiration Date: November 2, 2022
    • Molecular Phenotypes of Null Alleles in Cells (MorPhiC) Phase I: Data Analysis and Validation Centers (U01 Clinical trials not allowed)
      RFA-HG-22-019
      Application Due Dates: November 1, 2022
      Expiration Date: November 2, 2022
    • Technology Development for Single-Molecule Protein Sequencing (R43/R44 Clinical Trial not allowed)
      PAR-21-247
      Application Due Dates: October 1, 2021; June 15, 2022; June 15, 2023
      Expiration Date: June 16, 2023
    • Technology Development for Single-Molecule Protein Sequencing (R01 Clinical Trial not allowed)
      RFA-HG-21-001
      Application Receipt Date(s): October 1, 2021; June 15, 2022; June 15, 2023 |
      Expiration Date: June 16, 2023
    • Technology Development for Single-Molecule Protein Sequencing (R21 Clinical Trial not allowed)
      RFA-HG-21-002
      Application Receipt Date(s): October 1, 2021; June 15, 2022; June 15, 2023
      Expiration Date: June 16, 2023
    • Notice of Special Interest (NOSI): Advancing Genomic Technology Development for Research and Clinical Application
      NOT-HG-21-018
    • Transformative Nucleic Acid Sequencing Technology Innovation and Early Development (R01 Clinical Trial not Allowed)
      RFA-HG-21-006
      Application Receipt Dates: June 25, 2021; March 1, 2022; February 1, 2023
      Expiration Date: February 2, 2023
    • Transformative Nucleic Acid Sequencing Technology Innovation and Early Development (R21 Clinical Trial not Allowed)
      RFA-HG-21-007
      Application Receipt Dates: June 25, 2021; March 1, 2022; February 1, 2023
      Expiration Date: February 2, 2023
    • Transformative Nucleic Acid Sequencing Technology Innovation and Early Development (R43/R44)
      RFA-HG-21-008
      Application Receipt Dates: June 25, 2021; March 1, 2022; February 1, 2023
      Expiration Date: February 2, 2023
    • Notice of Special Interest (NOSI): High-throughput Molecular and Cellular Phenotyping
      NOT-HG-21-004

Meetings and Workshops

Division Staff

Leadership

Carolyn M. Hutter, Ph.D.
Carolyn M. Hutter, Ph.D.
  • Director
  • Division of Genome Sciences

Program Directors

Alexander Arguello
Alexander Arguello, Ph.D.
  • Program Director
  • Division of Genome Sciences
Lisa Chadwick
Lisa H. Chadwick, Ph.D.
  • Program Director
  • Division of Genome Sciences
di_Francesco
Valentina Di Francesco, M.S.
  • Chief Data Science Strategist
  • National Human Genome Research Institute
Elise Feingold
Elise Feingold, Ph.D.
  • Program Director
  • Division of Genome Sciences
Adam Felsenfeld, Ph.D.
Adam Felsenfeld, Ph.D.
  • Program Director
  • Division of Genome Sciences
Colin Fletcher, Ph.D.
Colin Fletcher, Ph.D.
  • Program Director, The Knockout Mouse Project (KOMP)
  • Division of Genome Sciences
Daniel A. Gilchrist, Ph.D.
Daniel A. Gilchrist, Ph.D.
  • Program Director
  • Division of Genome Sciences
Stephanie Morris
Stephanie A. Morris, Ph.D.
  • Program Director
  • Division of Genome Sciences
Mike Pazin, Ph.D.
Mike Pazin, Ph.D.
  • Program Director
  • Division of Genome Sciences
Ajay Pillai, Ph.D.
Ajay Pillai, Ph.D.
  • Program Director
  • Division of Genome Sciences
Shurjo Sen
Shurjo K. Sen, Ph.D.
  • Program Director
  • Division of Genome Sciences
Mike Smith
Mike Smith, Ph.D.
  • Program Director Genome Technology Program
  • Division of Genome Sciences
Jennifer Strasburger
Jennifer Strasburger, M.S.
  • Lead Genomic Program Administrator
  • National Human Genome Research Institute
Jennifer Troyer
Jennifer L. Troyer, Ph.D.
  • Program Director Human Heredity and Health in Africa
  • Division of Genome Sciences

Program Specialists

Ismail Safi
Ismail Safi, Pharm. D.
  • Scientific Program Specialist
  • Division of Genome Sciences

Program Analysts

Katie Bardsley
Katie Bardsley, B.S.
  • Scientific Program Analyst
  • Division of Genome Sciences
Jake Baroch
Jake Baroch, B.S.
  • Scientific Program Analyst
  • Division of Genome Sciences
Stephanie Callouri
Stephanie Calluori, B.A.
  • Scientific Program Analyst
  • Division of Genome Sciences
Sara Currin
Sara Currin, B.S.
  • Scientific Program Analyst
  • Division of Genome Sciences
Bri Foster
Bri Foster, B.S.
  • Scientific Program Analyst
  • Division of Genomics and Society / Division of Genome Sciences
Colette Pollard
Colette Pollard, B.A.
  • Scientific Program Analyst
  • Office of Genomic Data Science
Ella Samer
Ella Samer, B.S.
  • Scientific Program Analyst
  • Division of Genomic Medicine
Maya Vanzanten
Maya VanZanten, B.S.
  • Scientific Program Analyst
  • Division of Genome Sciences
Riley Wilson
Riley Wilson, B.S.
  • Scientific Program Analyst
  • Division of Genomic Medicine

Special Volunteers

Lisa Brooks
Lisa Brooks, Ph.D.
  • Volunteer
  • Division of Genome Sciences

Support Staff

Amalia M. Sobalvarro
Amalia M. Sobalvarro
  • Support Staff
  • Division of Genome Sciences

Related Resources

(Division Director) Teri Manolio and (Scientific Program Analyst) Katherine Sillari at the NHGRI Symposium poster session
Research Funding
Scientific Program Analysts

Last updated: October 21, 2022